InvestLog
DNA Ginkgo Bioworks Holdings, Inc. logo

DNA Ginkgo Bioworks Holdings, Inc.

Healthcare
$8.41+4.08%ClosedMarket Cap: $549.4M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.13

P/S

3.89

EV/EBITDA

-3.96

DCF Value

$-32.64

FCF Yield

-33.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

75.0%

Operating Margin

-210.7%

Net Margin

-215.4%

ROE

-57.3%

ROA

-29.5%

ROIC

-31.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$19.5M$-82.6M$—
Q4 null$33.4M$-80.8M$—
FY null$170.2M$-312.8M$—
Q3 null$38.8M$-80.8M$—

Analyst Ratings

View All

Consensus

Sell

Target (Consensus)

$7.84

Target (Median)

$7.50

Target Range

$4.35 - $12.00

0 Strong Buy1 Buy0 Hold1 Sell2 Strong Sell
BTIGSell
2026-03-12
TD CowenBuy
2026-01-08
BTIGSell
2025-08-25

Trading Activity

Insider Trades

View All
Coen Steven P.officer: See remarks
SellMon Apr 20
Coen Steven P.officer: See remarks
SellMon Apr 20
Coen Steven P.officer: See remarks
SellMon Apr 20
Coen Steven P.officer: See remarks
SellTue Apr 14
Coen Steven P.officer: See remarks
SellTue Apr 14

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

1.78

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Peers

ARVN logoARVNATXS logoATXSAVBP logoAVBPIOVA logoIOVAMBX logoMBXMGTX logoMGTXMRVI logoMRVIREPL logoREPLVALN logoVALNVIR logoVIR